| Title |
Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, November 2020
|
| DOI | 10.2147/ndt.s277294 |
| Pubmed ID | |
| Authors |
Hamza A Alsayouf, Haitham Talo, Marisa L Biddappa, Mohammad Qasaymeh, Shadi Qasem, Emily De Los Reyes |
X Demographics
The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Arab Emirates | 3 | 13% |
| Saudi Arabia | 2 | 9% |
| United Kingdom | 1 | 4% |
| Iraq | 1 | 4% |
| United States | 1 | 4% |
| Jordan | 1 | 4% |
| Unknown | 14 | 61% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 20 | 87% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
| Scientists | 1 | 4% |
| Practitioners (doctors, other healthcare professionals) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 53 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 6 | 11% |
| Student > Bachelor | 4 | 8% |
| Other | 4 | 8% |
| Researcher | 4 | 8% |
| Student > Ph. D. Student | 4 | 8% |
| Other | 5 | 9% |
| Unknown | 26 | 49% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 17% |
| Nursing and Health Professions | 5 | 9% |
| Psychology | 4 | 8% |
| Neuroscience | 3 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
| Other | 3 | 6% |
| Unknown | 27 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 59. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 December 2023.
All research outputs
#726,497
of 25,507,011 outputs
Outputs from Neuropsychiatric Disease and Treatment
#92
of 3,138 outputs
Outputs of similar age
#20,104
of 441,878 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 40 outputs
Altmetric has tracked 25,507,011 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,138 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,878 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.